Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCM) in a research report issued on Saturday. The brokerage set a “sell” rating on the stock.

Concord Medical Services Stock Down 3.4 %

Shares of Concord Medical Services stock opened at $4.44 on Friday. The business has a 50 day moving average price of $4.91 and a 200 day moving average price of $5.62. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.46 and a current ratio of 0.47. Concord Medical Services has a 1 year low of $3.82 and a 1 year high of $26.70.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.